Company Profile
Updated: 26-OCT-09Actelion Pharmaceuticals Ltd.
International public company
Gewerbestrasse 16, Allschwil, CH-4123, Switzerland
()41 061 487 34 58, 41 061 565 65 00 fax, http://www.actelion.com
Primary SIC: Pharmaceutical Preparations, Primary NAICS: Pharmaceutical Preparation Manufacturing
Description: Manufacturing: Bio-pharmaceutical company focusing on the research, development and marketing of synthetic small molecule drugs to treat and prevent diseases related to the endothelium. The clinical portfolio includes two drugs, tezosentan and bosentan, used in the treatment of heart failure and pulmonary hypertension
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
Findings in type 2 diabetes reported from Actelion Pharmaceuticals Ltd., Department of Clinical Pharmacology.(Clinical report)
Diabetes Week; 11/9/2009; 1131 words; ...contact P.N. Sidharta, Actelion Pharmaceuticals Ltd, Dept. of Clinical Pharmacology...Switzerland, Allschwil, Actelion Pharmaceuticals Ltd., Biotechnology Business...Dependent Diabetes Mellitus, Pharmaceutical Business, Pharmaceutical...
Other News To Note.
BIOWORLD Today; 11/4/2009; 2987 words; o Actelion Ltd., of Allschwil...very pleased that Actelion has achieved profitability...o BioSante Pharmaceuticals Inc., of Lincolnshire...Association of Pharmaceutical Scientists' AAPS...o ChondroGene Ltd., of Toronto...
Genentech's Avastin Phase III Misses Breast Cancer Endpoint.
BIOWORLD Today; 11/4/2009; 1304 words; ...bosentan), partnered with Switzerland-based Actelion Ltd., failed a Phase III trial for congestive heart...which is partnered with Melville, N.Y.-based OSI Pharmaceuticals Inc., suffered fallout from the failure of Iressa...
OGS Separating Business Into Three Units To Aid Transparency.
BIOWORLD Today; 11/4/2009; 1234 words; ...Formerly the global head of pharmaceuticals at Bayer AG, of Leverkusen...discovery programs with NeoGenesis Pharmaceuticals Inc., of Cambridge, Mass...Allschwil, Switzerland-based Actelion Ltd. to market and distribute...
Texas Bio Dissolves ICOS Venture, Regains Full Rights To Sitaxsentan.
BIOWORLD Today; 11/4/2009; 1484 words; ...of the year, also plans to rename itself Encysive Pharmaceuticals in the next month, following shareholder approval...Tracleer, developed by Allschwil, Switzerland-based Actelion Ltd. and co-promoted by South San Francisco-based...
Recent News Articles
- Research in the area of pharmacodynamics reported from Actelion Pharmaceuticals Ltd., Department of Clinical Pharmacology.(Report)
Biotech Week - May 06, 2009 - Study findings from Actelion Pharmaceuticals Ltd. broaden understanding of proteomics.
Biotech Week - October 15, 2008 - Pharmaceutical Pioneer Actelion Pharmaceuticals Ltd. Adopts Portfolio Management Solution for New Product Development from Artemis International.
Business Wire - April 27, 2004
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning
